Masimo Shareholders Approve Acquisition by Danaher

By Chris Stiles • Monday, May 04 11:44 • Permanent Link

Masimo shareholders approved the company’s acquisition by Danaher at a special meeting held virtually on May 1, 2026, clearing a key hurdle for the deal announced Feb. 16, 2026.

Under the merger terms, Masimo stockholders will receive $180.00 in cash for each share of common stock outstanding immediately before the merger closes. Masimo said it expects the transaction to close in 2026, pending customary closing conditions, including regulatory approvals and clearances.

The vote came after Masimo’s board backed the agreement with Danaher and Mobius Merger Sub. Chief Executive Katie Szyman said the approval marked “an important milestone” for the company and that the merger would position Masimo for continued global growth within Danaher’s diagnostics segment.

Masimo did not disclose the vote tally in the release. Following these announcements, the company's shares moved -0.04%, and are now trading at a price of $178.63. For the full picture, make sure to review MASIMO CORP's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.